Who are Vyome Holdings, Inc.'s main suppliers?

Vyome Holdings, Inc. (HIND) key suppliers include: REMUS-CAPITAL-SERIES-B-II-L-P, HUMANYZE, Sanofi, Sanofi. View the full supplier network at chainsifter.com/chain/HIND.

Who are Vyome Holdings, Inc.'s major customers?

Vyome Holdings, Inc. (HIND) key customers include: HUMANYZE, SUN-PHARMA, Sanofi, Sanofi. View the full customer network at chainsifter.com/chain/HIND.

What sector is Vyome Holdings, Inc. in?

Vyome Holdings, Inc. (HIND) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

HIND Supply Chain: Vyome Holdings, Inc. Supplier List & 11 Relationships

4Suppliers

4Customers

3Debt Items

20Related Chains

Vyome Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
REMUS-CAPITAL-SERIES-B-II-L-P	REMUS-CAPITAL-SERIES-B-II-L-P	92%	the Buyer will acquire senior secured convertible notes in the aggregate principal amount of $5,765,000 issued by Humanyze and held by Remus
HUMANYZE	HUMANYZE	85%	Remus will have the right to appoint one director to the LICH board immediately after closing. The LICH board and CEO will use their best efforts to raise capital as needed. As a condition to closing…
SNYNF	Sanofi	72%	or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or inval…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from HIND graph: or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination i…

Vyome Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
HUMANYZE	HUMANYZE	90%	following the Closing, Remus agreed to ensure that Humanyze remains active and in good standing for purposes of servicing select existing debts, liabilities, and other obligations
SUN-PHARMA	SUN-PHARMA	90%	various licensing agreements with Sun Pharma
SNYNF	Sanofi	72%	t such party. Costly and time- consuming litigation could be necessary to enforce and determine the scope of our proprietary rights and failure to obtain or maintain trade secret protection could adv…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from HIND graph: t such party. Costly and time- consuming litigation could be necessary to enforce and determine the scope of our pro…

Vyome Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
HIND-DEBT-3753	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
HIND-DEBT-3752	Warrants outstanding: 6008589	90%	xbrl warrant detail from xbrl 2025-12-31.
HIND-DEBT	Debt stack $22,548	90%	Market cache reports total debt of $22,548.

Vyome Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Vyome Holdings, Inc..

Vyome Holdings, Inc. Ownership

Holder	Name	Confidence	Evidence
HIND-OWNER-BANK-OF-AMERICA-CORPORATION	Bank of America Corporation	95%	13F/ownership overlay lists Bank of America Corporation; shares held 6; value $13; as of 2025-09-30.
HIND-OWNER-UBS-GROUP-AG	UBS Group AG	95%	13F/ownership overlay lists UBS Group AG; shares held 3,959; ownership 0.07%; value $8,670; as of 2025-12-31.
HIND-OWNER-HIGHTOWER-ADVISORS-LLC	HighTower Advisors, LLC	95%	13F/ownership overlay lists HighTower Advisors, LLC; shares held 17,973; ownership 0.32%; value $39,360; as of 2025-09-30.
HIND-OWNER-KOVITZ-INVESTMENT-GROUP-PARTNERS-LLC	Kovitz Investment Group Partners, LLC	95%	13F/ownership overlay lists Kovitz Investment Group Partners, LLC; shares held 14,640; ownership 0.26%; value $32,061; as of 2025-09-30.
HIND-OWNER-MORGAN-STANLEY	Morgan Stanley	95%	13F/ownership overlay lists Morgan Stanley; shares held 118; value $258; as of 2025-09-30.
HIND-OWNER-ROYAL-BANK-OF-CANADA	Royal Bank of Canada	95%	13F/ownership overlay lists Royal Bank of Canada; shares held 5,856; ownership 0.10%; value $12,824; as of 2025-09-30.
HIND-OWNER-VANGUARD-GROUP-INC	Vanguard Group Inc	95%	13F/ownership overlay lists Vanguard Group Inc; shares held 12,195; ownership 0.22%; value $26,707; as of 2025-12-31.

Vyome Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SNYNF	Sanofi	100.00	1	['customer', 'supplier']
VINP	Vinci Compass Investments Ltd.	100.00	2
ALXO	ALX Oncology Holdings Inc.	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
ANL	Adlai Nortye Ltd.	50.00	2
ANRO	Alto Neuroscience, Inc.	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2
CLDX	Celldex Therapeutics, Inc.	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2
CBIO	Crescent Biopharma, Inc.	50.00	2
RXRX	Recursion Pharmaceuticals, Inc.	50.00	2
CCEP	Coca-Cola Europacific Partners PLC	50.00	2
DSGN	Design Therapeutics, Inc.	50.00	2
AZN	AstraZeneca PLC	50.00	2
CRVS	Corvus Pharmaceuticals, Inc.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
DBVTF	DBV TECHNOLOGIES	50.00	2
EDIT	Editas Medicine, Inc.	50.00	2
LGND	Ligand Pharmaceuticals Incorporated	50.00	2
WHWK	Whitehawk Therapeutics, Inc.	50.00	2

Vyome Holdings, Inc. Supply Chain